FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2016/10/007384 [Registered on: 20/10/2016] Trial Registered Retrospectively
Last Modified On: 18/10/2016
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   A clinical trial to evaluate the effect preoperative intranasal Dexmedetomidine to decrease hypertensive response of laryngoscopy and endotracheal intubation in elective lumber spine surgery. 
Scientific Title of Study   A randomized, double blinded, placebo controlled clinical trial to evaluate the efficacy of intranasal Dexmedetomidine as premedicant to attenuate haemodynamic response of laryngoscopy and intubation in elective lumber spine surgery. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  ARKA DAS 
Designation  Post Graduate Trainee.  
Affiliation  I.P.G.M.E and R. Kolkata 
Address  224/4 Gorokshya Basi Road. Dum Dum. Kolkata-28

North Twentyfour Parganas
WEST BENGAL
700028
India 
Phone  9903368156  
Fax    
Email  doctor.arka@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR SAIKAT NIYOGI 
Designation  ASSOCIATE PROFESSOR  
Affiliation  BANGUR INSTITUE OF NEUROSCIENCES 
Address  OMM TOWER, 4NO MM FEEDER ROAD, BELGHORIA, KOLKATA

North Twentyfour Parganas
WEST BENGAL
700056
India 
Phone  9831732443  
Fax    
Email  saikatneuro1972@gmail.com  
 
Details of Contact Person
Public Query
 
Name  ARKA DAS 
Designation  Post Graduate Trainee.  
Affiliation  I.P.G.M.E and R. Kolkata 
Address  224/4 Gorokshya Basi Road. Dum Dum. Kolkata-28

North Twentyfour Parganas
WEST BENGAL
700028
India 
Phone  9903368156  
Fax    
Email  doctor.arka@gmail.com  
 
Source of Monetary or Material Support  
Bangur Institute of Neurosciences, Kolkata. Debendra Lal Khan Rd, S S K M Hospital, Bhowanipore, Kolkata, West Bengal 700020 
 
Primary Sponsor  
Name  Bangur Institute of Neurosciences Kolkata 
Address  Debendra Lal Khan Rd, S S K M Hospital, Bhowanipore, Kolkata, West Bengal 700020 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DRSAIKAT NIYOGIASSOCIATE PROFESSOR  Bangur Institute of Neurosciences, Neuroanesthesia department,Kolkata.  52/1A,SAMBHUNATH PANDIT STREET,KOLKATA7000025
North Twentyfour Parganas
WEST BENGAL 
9831732443

saikatneuro1972@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee of IPGMEandR, Kolkata  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  1. Preoperative anxiety and preoperative sedation. 2. Hemodynamic response to laryngoscopic surge and endotracheal intubation,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Diazepam, dexmedetomidinee  Oral Diazepam at 0.2 mg/kg body weight given 90 mins before induction, intranasal dexmedetomidine at 1 mcg/kg given 45 mins before induction. 
Intervention  not applicable  not applicable 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients with ASA physical status I, patients having Mallampati I and II, patients with body mass index (BMI) < 30 kg/m2. 
 
ExclusionCriteria 
Details  Patients refusal to participate in the study.Known allergy or hypersensitive reaction to dexmedetomidine or diazepam. Patients suffering from significant cardiac disease e.g IHD, cardiomyopathy, valvular disorder, hypertension, arrhythmia, etc. Patients suffering from significant respiratory disease e.g COPD, bronchial asthma, interstitial lung diseases, pneumonia etc. Patients having metabolic, endocrinal, musculoskeletal, neurologic disorder or having major congenital anomalies. History of drug abuse and/or psychiatric disorder. Pregnant women; no reliable contraceptive measures in postmenopausal women. Patients taking antihypertensive drugs such as methyldopa, clonidine and other α2 receptor agonists. Patients having morbid obesity, obstructive sleep apnoea, suspected difficult airway. Patients having liver and kidney dysfunction. Patients having long-term use of sedatives and analgesics. Patients having Mallampati grades III and IV. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Centralized 
Blinding/Masking   Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded 
Primary Outcome  
Outcome  TimePoints 
Sedation and preoperative reduction in anxiety.
Heart Rate (variation of 10 beats/min) and Blood pressure variation to laryngoscopy and endotracheal intubation. 
Sedation and anxiety upto 45 mins before induction of General anaesthesia, hemodynamic variation from preinduction upto 10 mins after endotracheal intubation. 
 
Secondary Outcome  
Outcome  TimePoints 
Any side effects including bradycardia and hypotension.  during the whole study period. 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/03/2015 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   preparing for publication in national journal 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This study is a randomized, double blinded placebo controlled trial comparing the safety and efficacy of Intranasal Dexmedetomidine (1 mcg/kg body weight) with Oral Daizepam (0.2 mg/kg body weight) versus intranasal placebo with Oral Diazepam ( 0.2 mg/kg body weight) only, in 70 adult patients undergoing elective lumbar spine surgery in 1 centre in India.
The primary outcome measures are:
1. Preoperative reduction in anxiety and preoperative sedation, measured upto 45 minutes prior to induction of anaesthesia.
2. Hemodynamic response measured by Heart Rate and Blood pressure variation to laryngoscopy and endotracheal intubation measured upto 10 mins after intubation.
 
Close